STRS Ohio’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-7,355
| Closed | -$970K | – | 2336 |
|
2025
Q1 | $970K | Sell |
7,355
-5,355
| -42% | -$706K | ﹤0.01% | 885 |
|
2024
Q4 | $1.06M | Sell |
12,710
-4,089
| -24% | -$342K | ﹤0.01% | 834 |
|
2024
Q3 | $1.23M | Buy |
16,799
+846
| +5% | +$61.9K | ﹤0.01% | 834 |
|
2024
Q2 | $1.09M | Sell |
15,953
-7,847
| -33% | -$537K | ﹤0.01% | 843 |
|
2024
Q1 | $1.65M | Sell |
23,800
-2,500
| -10% | -$173K | 0.01% | 718 |
|
2023
Q4 | $1.88M | Sell |
26,300
-1,600
| -6% | -$115K | 0.01% | 634 |
|
2023
Q3 | $1.45M | Buy |
27,900
+900
| +3% | +$46.9K | 0.01% | 740 |
|
2023
Q2 | $1.71M | Buy |
27,000
+6,300
| +30% | +$399K | 0.01% | 688 |
|
2023
Q1 | $1.12M | Sell |
20,700
-900
| -4% | -$48.7K | ﹤0.01% | 888 |
|
2022
Q4 | $1.14M | Sell |
21,600
-9,300
| -30% | -$492K | 0.01% | 884 |
|
2022
Q3 | $1.44M | Hold |
30,900
| – | – | 0.01% | 711 |
|
2022
Q2 | $1.76M | Buy |
30,900
+18,000
| +140% | +$1.03M | 0.01% | 649 |
|
2022
Q1 | $789K | Buy |
12,900
+4,600
| +55% | +$281K | ﹤0.01% | 1186 |
|
2021
Q4 | $434K | Buy |
8,300
+900
| +12% | +$47.1K | ﹤0.01% | 1524 |
|
2021
Q3 | $275K | Hold |
7,400
| – | – | ﹤0.01% | 1688 |
|
2021
Q2 | $302K | Buy |
+7,400
| New | +$302K | ﹤0.01% | 1717 |
|
2020
Q4 | – | Sell |
-2,900
| Closed | -$74K | – | 2301 |
|
2020
Q3 | $74K | Sell |
2,900
-2,000
| -41% | -$51K | ﹤0.01% | 1904 |
|
2020
Q2 | $125K | Buy |
+4,900
| New | +$125K | ﹤0.01% | 1746 |
|
2014
Q4 | – | Sell |
-2,370
| Closed | -$32K | – | 1863 |
|
2014
Q3 | $32K | Buy |
+2,370
| New | +$32K | ﹤0.01% | 1699 |
|